Sunshine entered into a two-year share purchase agreement for up to $2.5 million with Dutchess Opportunity Fund II. Sunshine Biopharma Inc. (OTCQB:SBFM), Montreal, Quebec Business: Cancer Date announced: 4/29/14 WIR Staff cancer...

ValiRx secured an equity line of credit facility for up to £3 million ($4.9 million) over two years with Dutchess Opportunity Fund II L.P. ValiRx plc (LSE:VAL), London, U.K. Business: Cancer, Diagnostic Date announced: 12/11/09...